LPL Financial LLC Has $2.19 Million Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

LPL Financial LLC raised its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 52.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 115,108 shares of the medical instruments supplier's stock after buying an additional 39,498 shares during the period. LPL Financial LLC owned about 0.06% of DENTSPLY SIRONA worth $2,185,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. MML Investors Services LLC grew its stake in DENTSPLY SIRONA by 2.1% in the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier's stock valued at $803,000 after purchasing an additional 620 shares in the last quarter. Barclays PLC lifted its holdings in shares of DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock valued at $8,301,000 after buying an additional 54,920 shares during the last quarter. M&T Bank Corp grew its stake in shares of DENTSPLY SIRONA by 5.6% in the 3rd quarter. M&T Bank Corp now owns 39,079 shares of the medical instruments supplier's stock valued at $1,058,000 after buying an additional 2,062 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $261,000. Finally, Tidal Investments LLC bought a new position in DENTSPLY SIRONA during the third quarter valued at approximately $602,000. 95.70% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY traded up $0.18 during mid-day trading on Friday, hitting $12.83. The company's stock had a trading volume of 2,841,795 shares, compared to its average volume of 2,964,258. The stock's 50-day moving average is $15.61 and its two-hundred day moving average is $18.69. The firm has a market capitalization of $2.56 billion, a PE ratio of -6.20, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $31.00.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.99%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

Analysts Set New Price Targets

XRAY has been the subject of several recent research reports. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and decreased their target price for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Evercore ISI restated an "in-line" rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Finally, Wells Fargo & Company cut their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. Thirteen research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $22.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.